# PersonalRX A home delivery pharmacy focused on improving patient outcomes. ## Elevator pitch PersonalRX makes it easy to take the right medications at the right time. We dispense them in multi-dose packs labeled with the patient's name, medication, dosage, and date/time of day. We deliver the medications to the home – with no added costs. Our pharmacy model puts the patient at the center of care. The focus is on enhanced safety, convenience, and better health outcomes. - Canonical URL: https://wefunder.com/personalrx - Entity ID: wefunder:company:67113 - Last updated: 2026-06-22T05:03:11Z - Generated at: 2026-06-22T15:58:59Z ## Quick facts - We've shipped 10 million Square Packs (dose packs) and generated revenue in excess of $26 million! - The pharmacy market is $500 billion annually. So we have plenty of room to grow. - We focus on the 41 million Americans who take 5 or more medications. - Our proprietary RX2 Mobile app and monthly "Care Calls" help us "surround the patient with care." - We are licensed and delivering patient medications in 38 states. - Our mission is to "Improve Lives" and patient healthcare through increased patient compliance. - Recent acquisitions in this market have totaled as high as $1 billion. - Relationship with Fortune 500 company. ## Active fundraises - wefunder:fundraise:37030: 4(a)(6) successful (USD) ## Story PersonalRX places the patient at the center of the pharmacy care model. We are a home delivery pharmacy providing VIP services and packaging to improve patient compliance — with no added costs. Our pharmacists are available 24/7, and each patient has the direct phone number of their dedicated pharmacy technician. We are in a hot market with a need for personalized innovation. In 2020, prescription drug expenditures total $358.7 billion. Pill Pack was acquired by Amazon for nearly $1 billion in Jue 2018. More recently, DivvyDose was acquired by UnitedHealth in September 2020 for $300 million. Bottom line - the pharmacy market is large enough for many companies to do well. Our services focus on the 12.6% of Americans who take 5 medications or more — a patient group in need of an easier synthesized medical solution. This equates to 41.3 million Americans and a market size that exceeds $126.4 billion annually. Our company is fully prepared to perform at scale with our proven sales model.We’re licensed in 38 states, and our traction is huge. We produced and delivered our 10 millionth Square Pack last year, in addition to onboarding a Fortune 500 Pharmacy Benefits Management company. This year, we began accepting referrals from a new Medicare Home Health partner with over 200 offices.We made an app for our patients.Since the inception of the PersonalRX brand in 2016, we’ve served and acquired a growing number of patients in the home delivery market. In 2019, we developed our digital platform — the RX2 Mobile app, a progressive web application (PWA). Available across iOS, Android, and Windows operating systems.We made a dashboard for us.We completed RX2 Admin in 2020, a proprietary Patient Relationship Management Tool (PRM) that drives end-to-end workflow for pharmacy home delivery — from billing and day-to-day communication to packing and shipping. This makes it simple for us to provide the best service with efficiency. Our workflows are automated, utilizing pharmacy robots for faster-than-manual processes.Our goal is to lead the pharmacy industry in providing excellent patient care, nationwide. PersonalRX has the infrastructure, experience, team, and business relationships to operate at scale.COVID-19 has created a “new normal” in creating a desire for a contactless experience. We’re bringing a sanitary solution right to your doorstep, and we’ve built a scalable business that continues to grow as we reinvest in it. Our subscription model builds revenue quickly, leading to significant profits and a rewarding ROI for investors.We’re more than pill packers. We’re delivering healthcare. While our competitors deliver individual medications, we deliver a full-service, personalized experience that protects the patient while improving care outcomes. PersonalRX is technology-enabled, not technology dependent. In other words, we use technology to drive workflow. But hiring great people who provide the personal touch is paramount for superb healthcare. All told, our team totals 100+ years of experience in entrepreneurship, pharmaceuticals, management, and business development. Merging technology and human compassion, we are fueling the next generation of retail pharmacy and we hope you’ll consider fueling this movement. The opportunity for investors is to enter early in our growth cycle, with a promising market in need of innovation. Join us to fuel the next generation of healthcare. ## FAQ 1. **Hi. What was your 2020 revenue? What are your revenue goals for the next 5 years?** - Hi Leonardo, Our 2020 revenue was $1,670,000, and here's the breakdown of our revenue goals for the next five years: 2021: $7,800,000 2022: $56,000,000 2023: $136,000,000 2024: $200,000,000 2025: $287,000,000 During that timeframe, we additionally aim to onboard 70,000 patients, open at least one additional fulfillment center on the West coast, and enjoy margin expansion. Although we cannot guarantee any projections, we're confident that we can meet our goals. Our solution is in high demand, ... 2. **Hi Lawrence, Can you briefly explain why you saw a dip in revenues during the 2019 fiscal year?** - Hi Joshua, Great question! We transitioned from working with 'seasonal' patients who take about 2 medications to 'year-round patients' that stay on service much longer and require many more medications. As such when we stopped working with summer camps and some boarding schools, and we had a dip in revenue. As an aside, given COVID, this turned out to be the right to make the transition as last summer there were few summer camps in session. I sincerely appreciate your question and interest in... 3. **Hi Lawrence, very much interested to know more as it is definitely an area where not many players exist. How do you differentiate yourself from Pillpack or NowRx. What are your customer acquisition expenses and business expansion strategies ? Extrapolation of prior 3 months re...** - Abhishek, Thank you for your interest in PersonalRX. You have asked some terrific questions. 1) How do you differentiate yourself from Pillpack or NowRx? Our dedicated monthly care calls and Caregiver app are key to our differentiator. Every patient in our network gets a personalized level of service that we have found translates to improved patient compliance, especially in elderly patients. We additionally offer private label co-branding; an option offered by none of our competitors. 2) We ... 4. **Hi, how many months the business can keep operating before it's out of money? Also, can you tell us more about margins? Thank you.** - Manuel, Thank you for your interest in PersonalRX. Currently, we have runway for several months as we raise the capital required to continue our growth trajectory. In terms of margin, the National Community Pharmacy Association (NCPA) reflects that margins across the country with average annual revenue of $3 Million were 22% on average. Obviously, larger pharmacies would benefit from margin expansion and thus margins would increase. Please let me know if you have any further questions. I look... 5. **Wefunder never Explains what our investment purchases... Common Stock, yearly% etcetera..been trying to see what my $300 dollars gets me.. CANT FIND IT? Suggestion... Copy Start Engine format...** - Hi Antonio, our investors receive a Future Equity Agreement (SAFE) with a valuation cap of $30M. You can find more details on SAFEs here: https://help.wefunder.com/contracts/304785-safe-simple-agreement-for-future-equity ## Team - Lawrence Margolis (Founder/CEO) - Charles Oestreicher (President and Chief Operating Officer) - Vaibhav Kullar (Chief Technology Officer) - Gillian Giannone, PharmD, R. Ph. (Director of Pharmacy Operations) - Dana Stripling (Director of Training and Patient Experience) - Cheryl Fine (Controller and Director of Talent) - Gregg Kattine (Advisor - Healthcare Relationships) ## Q&A - Q: Hello! I just found out that DGN Pharmacy dba Personal RX filed for bankruptcy a couple weeks ago. Does anyone have additional or contrary information about this and any idea if we, as investors, have any recourse? - Q: hi the last update was in 2021 whats going on with personalRx and will the shareholders like me will we be hearing anything soon - Q: do personalrx have a personal to see how things going - Q: its been awhile sensei have hear anything so im jsut checking for updates are yall plans as far as going IPO or nasdaq - Q: How many customers do yoou have? - Q: Are you all able to send controlled medications? - Q: What is the year-to-date revenue, and are you on track to hit your revenue projections for 2021? - A: Kevin, thank you for your question. Unfortunately, I do not believe we are allowed to answer this question from a compliance point of view. I have asked our team if it is permissible and will reply if permitted to do so. Thank you very much for your interest. - Q: Do you have any idea about personalized vitamin subscription? If you provide not only prescription drugs but also personalized, expert-selected vitamins, it would be better. - A: Currently, we package vitamins and supplements for our patients. We are investigating the profitability of providing an online service for these items alone. However, our current focus is to assist the 41 million Americans who take 5 or medications. - Q: Is it possible to partner with you after the investment to launch your solution in my country Ghana? - A: Sorry for the delayed response. At this time our licensing and focus are in the US. We will work with partners to consider international expansion in late 2022. - Q: Hi Lawrence, is it possible to change the minimum amount to invest to $100? - A: Hi Brandon, Thanks for reaching out today. Unfortunately, we cannot adjust the investment minimum at this time. If something should change and we are permitted to do so, we will let you know. I sincerely, appreciate your interest. Lawrence. - Q: I notice you send one month at a time to subscribers. How is this different from patients that are mandated a 3 month supply at once. Additionally, are you a provider for many benefit programs? If so, please provide. Thank you - A: Hi Cathy, There are many reasons we send a 30-day supply instead of 90. 1) A 90 day supply of packaged medications becomes unwieldy for patients as it would be delivered in at least 3 separate boxes given the size, 2) More importantly, when there is a medication change there is a lot of waste with 90-day supplies. 3) Mail order pharmacies send big bottles with a 90 supply which in some cases could amount to several hundred pills and the difficult customer experience of sorting these medications. Shipping in 30-day supplies provides better compliance/adherence for patients, more efficient service, and in regard to waste a less expensive option. In terms of benefit programs, we are contracted with thousands of plans both through the largest Pharmacy Benefit Manager (such as CVS Health and Express Scripts) as well as smaller PBMs. Our contracting teams continue to add additional contracted relationships as our patients request and in anticipation of those requests. As an example, one of our large PBM partners asked us for access to State Medicaid programs and we were recently granted licenses in 7 states for these Medicaid programs. Thanks for checking in with us! Lawrence. - Q: Wefunder never Explains what our investment purchases... Common Stock, yearly% etcetera..been trying to see what my $300 dollars gets me.. CANT FIND IT? Suggestion... Copy Start Engine format... - A: Hi Antonio, our investors receive a Future Equity Agreement (SAFE) with a valuation cap of $30M. You can find more details on SAFEs here: https://help.wefunder.com/contracts/304785-safe-simple-agreement-for-future-equity - Q: Hi, how many months the business can keep operating before it's out of money? Also, can you tell us more about margins? Thank you. - A: Manuel, Thank you for your interest in PersonalRX. Currently, we have runway for several months as we raise the capital required to continue our growth trajectory. In terms of margin, the National Community Pharmacy Association (NCPA) reflects that margins across the country with average annual revenue of $3 Million were 22% on average. Obviously, larger pharmacies would benefit from margin expansion and thus margins would increase. Please let me know if you have any further questions. I look forward to you joining the growing team of PersonalRX investors! Lawrence- - Q: Hi Lawrence, very much interested to know more as it is definitely an area where not many players exist. How do you differentiate yourself from Pillpack or NowRx. What are your customer acquisition expenses and business expansion strategies ? Extrapolation of prior 3 months revenue lands at 2M for 2021, however I see higher expectations (in your response ) . Please can you share details on the debt you carry and why/how did you accrue them. Your cash in hand per Sep was not enough to keep you afloat based on your operational expenses , how are you keeping the operations going or is the fund raise to continue operations ? Appreciate your time and patience in reading through my questions - A: Abhishek, Thank you for your interest in PersonalRX. You have asked some terrific questions. 1) How do you differentiate yourself from Pillpack or NowRx? Our dedicated monthly care calls and Caregiver app are key to our differentiator. Every patient in our network gets a personalized level of service that we have found translates to improved patient compliance, especially in elderly patients. We additionally offer private label co-branding; an option offered by none of our competitors. 2) We acquire patients through several channels including, direct-to-consumer marketing, PBM relationships, Insurance company partnerships, and of course referrals from our happy and healthy customers. Our patient acquisition costs vary considerably for our diverse marketing channels. 3) Our goal is to continue our growth and expansion through these sales channels. We have been planting seeds for some time now and it is wonderful to see how the growth translates to new patient onboarding. 4) We are raising capital to further expand our platform, acquire additional patients, and in part to fund ongoing operations. Previously we have funded operations through debt as reflected in our financials. This capital, allowed us to build our platform, provide unparalleled service, and develop our technology systems and processes to accommodate considerable growth and scale. Lawrence. - Q: Hi Lawrence, Can you briefly explain why you saw a dip in revenues during the 2019 fiscal year? - A: Hi Joshua, Great question! We transitioned from working with 'seasonal' patients who take about 2 medications to 'year-round patients' that stay on service much longer and require many more medications. As such when we stopped working with summer camps and some boarding schools, and we had a dip in revenue. As an aside, given COVID, this turned out to be the right to make the transition as last summer there were few summer camps in session. I sincerely appreciate your question and interest in PersonalRX! Lawrence.